Oncomed Pharmaceuticals Inc (OMED) Return on Investment ROI from the fourth quarter of 2018 to fourth quarter of 2017 and for the year 2018, average high and low, overall ranking from Dec 31 2018 to Dec 31 2017 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Oncomed Pharmaceuticals Inc  (OMED)


Oncomed Pharmaceuticals Inc's ROI from its fourth quarter of 2018 to the fourth quarter of 2017 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Oncomed Pharmaceuticals Inc's ROI in the fourth quarter of 2018?
Oncomed Pharmaceuticals Inc recorded a cumulative net loss of $-8 million during 12 months ending in the fourth quarter of 2018, resulting in a negative return on investment (ROI) of -14.65%.

Within the Healthcare sector 237 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the third quarter of 2018 from 0 to 3515.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Dec 31 2018)
IV. Quarter		 (Sep 30 2018)
III. Quarter		 (Jun 30 2018)
II. Quarter		 (Mar 31 2018)
I. Quarter		 (Dec 31 2017)
IV. Quarter
Y / Y Investment Change TTM -14.48 % -71.92 % -70.22 % -63.2 % -55.89 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 52 56 53 60 -44
Return On Investment (TTM) -14.65 % 19.4 % -27.88 % -43.74 % -
OMED's Overall Ranking # 3515 # 0 # 0 # 0 # 0
Seq. Investment Change TTM 77.94 % -19.61 % -23.23 % -22.12 % -41.58 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -8 6 -11 -22 -39

OMED Company Profile >> Back to OMED Roi Comparisons >> See Annual OMED Return On Investment



Return On Investment OMED's Ranking
Within: No.
Industry # 87
Sector # 238
Overall # 3515

Return On Investment Statistics
High Average Low
41.91 %
-30.16 %
-71.98 %
(Dec 31 2013)   (Mar 31 2017)







Financial Statements
Oncomed Pharmaceuticals Inc's IV. Quarter Investments $ 52 Millions OMED's Balance sheet
Oncomed Pharmaceuticals Inc's IV. Quarter Income $ -5 Millions Quarterly OMED's Income Statement
OMED's Income by Division See OMED's Income by Division


OMED Annual Return On Investment (Dec 31 2018)
2018		 (Dec 31 2017)
2017		 (Dec 31 2016)
2016		 (Dec 31 2015)
2015		 (Dec 31 2014)
2014
Total Investments in Millions 52 17 140 185 209
Y / Y Investment Growth 205.03 % -87.69 % -24.63 % -11.49 % -22.96 %
Net Income in Millions -8 -39 -103 -85 -50
Y / Y Net Income Growth - - - - -
Annual Return On Investment -15.45 % -227.24 % -73.84 % -46.1 % -23.89 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
OMED's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for OMED's Competitors
Subscribers only: Roi for Oncomed Pharmaceuticals Inc's Suppliers
Subscribers only: Return On Investment for OMED's Customers

Other Ratios
OMED's Roa OMED's Inventory Turnover Ratio OMED's Growth Rates OMED's Dividend Statistics
OMED's Profitability Ratios OMED's Asset Turnover Ratio OMED's Dividend Growth
OMED's Roe OMED's Valuation Ratios OMED's Financial Strength Ratios OMED's Dividend Payout Ratio



Companies with similar Return On Investment at Dec 31 2018, within Healthcare Sector ROI

Date modified: 2026-09-26T08:31:15+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.